CardiologyNOW: A Pri-Med Virtual Conference


Join your clinician colleagues and expert faculty for CaradiologyNOW: A Pri-Med Virtual Conference, on Thursday, June 17.

This free day of learning, headlined by expert cardiologist Peter Libby, MD, will provide you with cardiology-focused sessions and offer timely medical updates to keep you informed on the most current clinical strategies relevant to your daily practice.
Earn up to 4.00 AMA PRA Category 1 Credits™ and 4.00 ABIM Medical Knowledge MOC Points, or 4.00 AANP contact hours of continuing education, including 1.18 hours of pharmacology, by attending the full day of online education.
Your free registration includes the full conference, but feel free to join the sessions that work with your schedule. 
 
Agenda and details are subject to change.
To register for this virtual conference, you will be asked to sign in to your Pri-Med account. If you do not have an account, you can create your free account now, which takes less than two minutes.

Agenda

  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

8–9am ET    CME/CE Accredited Session

Cardiology

 

With the COVID-19 pandemic moving through the country, it is important for clinicians to have the most up-to-date information. Join this session with Dr. Peter Libby to learn about the cardiovascular complications of COVID-19 and how you can help patients facing these issues. 

Peter Libby, MD

Cardiovascular Specialist, Brigham and Women's Hospital, Mallinckrodt Professor of Medicine, Harvard Medical School, Boston, MA

9:10–10:10am ET    CME/CE Accredited Session

Cardiology

Cardiovascular Risk Reduction: Optimizing Patient Identification for Improved Cardioprotective Outcomes 

Erin D. Michos, MD, MHS | Pamela Morris, MD, FACC, FAHA, FASPC, FNLA

 

In this virtual, case-based medical education program held during CardiologyNOW 2021, expert faculty will get to the heart of the matter by discussing how to identify patients who are still at risk for cardiovascular events and may benefit from additional treatment despite management of other risk factors.

Erin D. Michos, MD, MHS

Associate Professor of Medicine & Epidemiology, Director of Women’s Cardiovascular Health, Associate Director of Preventive Cardiology, Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD

Pamela Morris, MD, FACC, FAHA, FASPC, FNLA

Professor of Medicine, Cardiology, Director, Seinsheimer Cardiovascular Health Program, Co-Director, Women's Heart Care, Medical University of South Carolina, Charleston, SC

Supported by Amarin Pharma Inc.

10:20–11:05am ET    Non-CME Industry Theater

Cardiology

 

  • Understand the disease burden and pathophysiology for acute ischemic stroke (AIS), and appreciate the underlying alterations in platelet physiology and phenotype in the context of AIS or high-risk transient ischemic attack (TIA).
  • Learn about the use of BRILINTA in patients with AIS and high-risk TIA and the differentiation of P2Y12 inhibitor use in this patient population
  • Appreciate the evidence and indications for BRILINTA across the spectrum of atherosclerotic and atherothrombotic disease by understanding the BRILINTA Pivotal Trials and the recently published THALES Trial
 

Ted Okerson, MD, FACP, FACE

Dr. Okerson currently serves as a Sr. Field Physician within the Biopharmaceuticals US Medical Team for AstraZeneca’s Division of Cardiovascular and Metabolic Diseases. Dr. Okerson has a diverse medical and scientific background, with over 15 years of full-time clinical practice and leadership experience. For the past twenty years, he has exemplified a successful transition to industry, working as a Medical Director in various aspects of the pharmaceutical industry from clinical trial design to late phase clinical development and medical affairs for various well-known companies. In his current role, Dr. Okerson educates HCPs, works across specialties for internal collaborations, and strives to improve patient care.

Sponsored by AstraZeneca Pharmaceuticals, LP

11:15am–12:15pm ET    CME/CE Accredited Session

Cardiology

 

This activity aims to integrate new evidence on the treatment of CHD-PAH into clinical practice, by providing HCPs with a review of CHD-PAH pathophysiology, practical strategies for risk assessment based on underlying CHD and attributes of PAH, and evidence supporting the use of PAH therapies in patients with CHD-PAH.

Ioana R. Preston, MD

Pulmonary Function Lab Director, Director, Pulmonary Hypertension Center, Associate Professor, Tufts University School of Medicine, Boston, Massachusetts

Richard Krasuski, MD, FACC, FAHA, FESC

Professor of Medicine and Pediatrics, Director of the Adult Congenital Heart Disease Center, Director of Hemodynamic Research, Medical Director, CTEPH Program, Director of the Duke University Collaborative Cardiovascular Society (DUCCS), Duke University Medical Center, Durham, North Carolina

Supported by an educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.

12:25–1:25pm ET    CME/CE Accredited Session

Cardiology

Polyvascular Patients: Are You Doing Enough to Reduce Risk of Recurrent Events? 

Christian T. Ruff, MD, MPH | Elaine Hylek, MD, MPH

 

Cardiology expert, Christian Ruff, MD, MPH & primary care specialist, Elaine Hylek, MD, MPH will review the latest research and recommendations for patients with polyvascular disease.  The faculty also will discuss patient cases that cover long-term atherothrombotic risks, chronic coronary artery disease (CAD)/peripheral artery disease (PAD), benefits of direct oral anticoagulants (DOACs), and considerations for the multidisciplinary team.

Christian T. Ruff, MD, MPH

Assistant Professor of Medicine, Harvard Medical School, Investigator, TIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA

Elaine Hylek, MD, MPH

Professor of Medicine, Boston University School of Medicine, Director, Thrombosis and Anticoagulation Service, Boston Medical Center, Boston, MA

Supported by Janssen Scientific Affairs, LLC

1:35–2:20pm ET    Non-CME Industry Theater

Cardiovascular Medicine

 

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras laoreet vestibulum eros, ut egestas est consequat ut. Sed dignissim massa ac velit luctus, ut egestas est tincidunt. Sed et consequat lacus. Ut malesuada ligula vel nisi suscipit mollis. Aenean elementum ullamcorper faucibus. Donec luctus ante vel orci elementum porttitor. Nullam suscipit libero nec consectetur venenatis.

Sponsored by Not Applicable